The AI-Native OS for Discovery and Development

BioKit is built for life sciences teams who need the full picture. Strategy, business development, investor relations, and leadership teams use BioKit to track clinical progress, competitive landscapes, and market positioning with unified data and AI-powered research.

We'll offer flexible pricing for teams of all sizes. Early waitlist members will receive special pricing. Enterprise plans with advanced features will be available at launch.

BioKit connects what's usually siloed: clinical trial data, scientific research, SEC filings, and market intelligence. Instead of jumping between terminals, databases, and spreadsheets, your team gets the full context in one AI-native workspace.

BioKit is launching in late 2026. Join the waitlist to be among the first to access the platform and receive exclusive early-bird pricing.

Absolutely. BioKit is built with security-first principles. Your data is encrypted at rest and in transit, and we're working toward SOC 2 compliance for enterprise customers.

BioKit brings together clinical trial databases, SEC filings (13F, Form 4), real-time market data, and scientific literature. We're continuously adding new sources based on customer needs.